Rhelion Life Sciences Company Description

Rhelion Life Sciences Corp. engages in the research and development of psychedelic drug in Netherlands, Canada, and the United States.

Its products also include PEX010, a natural psilocybin drug candidate. It also engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe, as well as selection, distribution, and export of truffles.

The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026.

Rhelion Life Sciences Corp. is based in Toronto, Canada.

Rhelion Life Sciences Corp.

Country	Canada
Industry	Security Brokers, Dealers, and Flotation Companies
CEO	Todd Shapiro

Contact Details

Address: 1 Adelaide Street East Toronto, ON M5C 2V9 Canada
Phone	647 204 7129
Website	rhelion.com

Stock Details

Ticker Symbol	RHEL
Exchange	Canadian Securities Exchange
Fiscal Year	April - March
Reporting Currency	CAD
SIC Code	6211

Key Executives

Name	Position
Todd Shapiro	Chief Executive Officer
Samiuddin Khaja	Chief Financial Officer
Lisa Ranken	Chief Operating Officer